Volver a Agenda
Session 3, Track B: Equity, Diversity, Inclusion and Accessibility (EDIA) in Trials
Session Chair(s)
Rebecca Barnes, MS
Executive Director
Network of Networks (N2), Canada
Equity, diversity, inclusion and accessibility (EDIA) in clinical trial participants is an important topic to ensure the benefits of trials are shared by everyone. Clinical trials have often lacked representation from various equity-denied groups and Canada is well positioned to conduct clinical trials in a way that addresses these historical shortfalls. In this session, speakers will describe strategies to help sites and sponsors in improving EDIA in clinical trials, including early patient and community engagement, site selection, and use of AI and technology. Two communities this session will focus on are new immigrants to Canada, and members of the sexually and gender diverse community.
Learning Objective :
Speaker(s)
![Representative Invited](/_Images/member/Generic_Image_Missing-Profile.jpg)
Representative Invited
AxialBridge, Canada
Bridging the Gap: Advancing New Immigrant Participation in Clinical Trials to Enhance Diversity
Munaza Jamil
McMaster University/N2 [canada], Canada
Faculty, Applied Clin Research Program
¿Tiene una cuenta?